Boddaert, N
Salvador, A
Chandesris, M O
Lemaître, H
Grévent, D
Gauthier, C
Naggara, O
Georgin-Lavialle, S
Moura, D S
Munsch, F
Jaafari, N
Zilbovicius, M
Lortholary, O
Gaillard, R
Hermine, O
Article History
Received: 21 December 2016
Revised: 6 April 2017
Accepted: 20 April 2017
First Online: 8 August 2017
Competing interests
: RG has received compensation as a member of the scientific advisory board of Janssen, Lundbeck, Roche and Takeda. He has served as a consultant and/or speaker for Astra Zeneca, Pierre Fabre, Lilly, Otsuka, SANOFI, Servier and received compensation, and he has received research support from Servier. OH received research funding and honorarium from AB Science, and research grant from Novartis, Celgene, Hybrigenics, Inatherys Bristol Myer Squibb and Takeda. The remaining authors declare no conflict of interest.